Clinical trial · Observational
Study Into the Use of Electrical Impedance Mammography in the Diagnosis and Characterisation of Breast Disease
Use of Non-invasive Electrical Impedance Mammography in the Detection, Diagnosis and Characterisation of Breast Lesions
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Signascan Electrical Impedance Mammography (EIM) Study is a pilot study of a non-invasive medical device - a novel approach to breast cancer detection using Electrical Impedance Mammography (passing minute electrical currents through the tissues and detecting the changes to the currents as a result of the tissues, which can differentiate between normal and malignant tissue). The trial is a prospective trial of diagnostic capability of the device, as compared with standard care (diagnosis provided by the concurrent NHS investigation - imaging, surgery etc) performed for female patients attending the symptomatic breast clinic for investigation. The aim is to assess the diagnostic efficacy in detecting 100 true malignancies, and continue to recruit until 300 patients with true malignancies have been recruited if necessary.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Breast scan - Electrical Impedance Mammography | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Attendees to symptomatic breast clinic
- interventionNames
- Procedure: Breast scan - Electrical Impedance Mammography
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study * Female, aged 18 years or above * Attending for investigation of symptomatic breast lump Exclusion Criteria: * Pacemaker or critical implanted electronic device * Under the age of 18 years * Adults with learning disabilities * Adults who are unconscious or very severely ill * Adults who have a terminal illness * Adults in emergency situations * Adults suffering from a mental illness * Adults with dementia * Prisoners * Young offenders * Adults who are unable to consent for themselves * Any person considered to have a particularly dependent relationship with investigators * Any others deemed to belong to a vulnerable group
References
Publications (0)
Data not yet available